β¨ Medicines Distribution Consent
17 MAY
NEW ZEALAND GAZETTE
1135
Product:
Metalyse
Active Ingredient(s):
Tenecteplase 50mg
Dosage Form:
Powder for injection
New Zealand Sponsor:
Boehringer Ingelheim (NZ) Limited
Manufacturer(s):
Boehringer Ingelheim Pharma KG, Biberach an der Riss, Germany
Product:
Pacific Cefaclor 125
Active Ingredient(s):
Cefaclor (monohydrate) 26.22mg/mL equivalent to 25mg/mL cefaclor
Dosage Form:
Powder for oral suspension
New Zealand Sponsor:
Pacific Pharmaceuticals Limited
Manufacturer(s):
Merck Farma y Quimica SA, Poligono Merck, Mollet del Valles, Barcelona, Spain
Product:
Pacific Cefaclor 250
Active Ingredient(s):
Cefaclor (monohydrate) 52.45mg/mL equivalent to 50mg/mL cefaclor
Dosage Form:
Powder for oral suspension
New Zealand Sponsor:
Pacific Pharmaceuticals Limited
Manufacturer(s):
Merck Farma y Quimica SA, Poligono Merck, Mollet del Valles, Barcelona, Spain
Product:
Panadol Gel Tabs
Active Ingredient(s):
Paracetamol 500mg/dose
Dosage Form:
Coated tablet
New Zealand Sponsor:
SmithKline Beecham (NZ) Limited
Manufacturer(s):
Banner Pharmacaps Inc, Chatsworth, California 91311, United States of America
SmithKline Beecham (Australia) Pty Limited, Consumer Healthcare, Ermington, New South Wales, Australia
SmithKline Beecham (Dungarvan) Limited, Knockbrack, Dungarvan, Co. Waterford, Ireland
Dated this 7th day of May 2001.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go3283
Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product:
Chirocaine
Active Ingredient(s):
Levobupivacaine hydrochloride 2.816mg/mL equivalent to 2.5mg/ml levobupivacaine
Dosage Form:
Solution for injection
New Zealand Sponsor:
Abbott Laboratories (NZ) Limited
Manufacturer(s):
Antigen Pharmaceuticals Limited, Roscrea, Co. Tipperary, Eire
Note: This consent is valid for 2 years from the date of publication of this notice.
Product:
Chirocaine
Active Ingredient(s):
Levobupivacaine hydrochloride 5.633mg/mL equivalent to 5mg/mL levobupivacaine
Dosage Form:
Solution for injection
New Zealand Sponsor:
Abbott Laboratories (NZ) Limited
Manufacturer(s):
Antigen Pharmaceuticals Limited, Roscrea, Co. Tipperary, Eire
Note: This consent is valid for 2 years from the date of publication of this notice.
Product:
Chirocaine
Active Ingredient(s):
Levobupivacaine hydrochloride 8.449mg/mL equivalent to 7.5mg/mL levobupivacaine
Dosage Form:
Solution for injection
New Zealand Sponsor:
Abbott Laboratories (NZ) Limited
Manufacturer(s):
Antigen Pharmaceuticals Limited, Roscrea, Co. Tipperary, Eire
Note: This consent is valid for 2 years from the date of publication of this notice.
Dated this 7th day of May 2001.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go3284
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2001, No 50
Gazette.govt.nz —
NZ Gazette 2001, No 50
β¨ LLM interpretation of page content
π₯ Consent to Distribution of New Medicines
π₯ Health & Social Welfare7 May 2001
Medicines Act 1981, New Medicines, Distribution Consent, Pharmaceuticals
- G. R. BOYD, Chief Advisor, Safety and Regulation
π₯ Provisional Consent to Distribution of Chirocaine
π₯ Health & Social Welfare7 May 2001
Medicines Act 1981, Provisional Consent, New Medicine, Chirocaine, Levobupivacaine
- G. R. BOYD, Chief Advisor, Safety and Regulation